Home Search
omalizumab - search results
If you're not happy with the results, please do another search
Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3 Trial
Assessment for both single agent and add-on therapy.
United Biopharma’s Monoclonal Antibody Shows Promise in Neutralizing IgE
Shows promise for the treatment of chronic spontaneous urticaria, food allergies, asthma and eczema.
Halsey Diagnosed with Mast Cell Activation Syndrome and a Host of Other Ailments. What...
Singer hospitalized for anaphylaxis numerous times.
Making the Impossible, Possible: Redefining How Peanut Allergies are Diagnosed (Sponsored)
Never before has a blood test been able to help you make the decisions you face every single day living with food allergies.
Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple Foods
NIH and partners to assess whether Omalizumab can reduce allergic reactions.
OIT is a Therapy, Not an Ideology
The decisions we all face as patients and caretakers depend on the individual, their allergies, their lifestyles and myriad other factors.
Must See: 'ViewFinder: Food for Thought – Food Allergies'
This documentary should be required viewing for everyone as the food allergy epidemic has affected so many in the community.
Study: Allergic Reactions Frequent in Children Undergoing Milk OIT
Allergic reactions frequently occur during treatment and a significant proportion can be classified as anaphylactic, according to a new Canadian study.
Study: Anti-IgE Shots During Pregnancy May Provide a Lifetime of Protection from Allergies in...
"We discovered that preventing infant mice from creating antibodies would effectively diminish the risk of allergies in their adult lives."
FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies
Breakthrough Therapy Designation was granted on the basis of data from seven clinical studies assessing the efficacy and safety of Xolair against a range of food allergens including peanut, milk, egg and others.